These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 12840663)
21. [Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study]. Goday A; Gabriel R; Ascaso JF; Franch J; Ortega R; Martínez O; Lerones N; Rev Clin Esp; 2008 Sep; 208(8):377-85. PubMed ID: 18817695 [TBL] [Abstract][Full Text] [Related]
22. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Milani RV; Lavie CJ Am J Cardiol; 2003 Jul; 92(1):50-4. PubMed ID: 12842245 [No Abstract] [Full Text] [Related]
24. Metabolic syndrome, inflammation and atherosclerosis. Paoletti R; Bolego C; Poli A; Cignarella A Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458 [TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome: a marker of patients at high cardiovascular risk. Lau DC; Yan H; Dhillon B Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518 [TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis? Milionis HJ; Florentin M; Giannopoulos S CNS Spectr; 2008 Jul; 13(7):606-13. PubMed ID: 18622365 [TBL] [Abstract][Full Text] [Related]
27. Metabolic Syndrome Over 4 Years Before the Onset of Cardiovascular Disease - Nested Case-Control Study. Hu H; Nakagawa T; Honda T; Yamamoto S; Nanri A; Konishi M; Okazaki H; Kuwahara K; Hori A; Nishiura C; Kashino I; Imai T; Nishihara A; Akter S; Miyamoto T; Sasaki N; Ogasawara T; Uehara A; Yamamoto M; Murakami T; Shimizu M; Eguchi M; Kochi T; Nagahama S; Tomita K; Kabe I; Mizoue T; Sone T; Dohi S; Circ J; 2018 Jan; 82(2):430-436. PubMed ID: 28931789 [TBL] [Abstract][Full Text] [Related]
28. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome. Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871 [TBL] [Abstract][Full Text] [Related]
29. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ; Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684 [No Abstract] [Full Text] [Related]
30. Preventing cardiovascular and renal complications in the management of hypertension and metabolic syndrome. Chen J; Townsend RR Expert Opin Pharmacother; 2007 Sep; 8(13):2001-9. PubMed ID: 17714054 [TBL] [Abstract][Full Text] [Related]
31. Equality or disparity? Cardiovascular risk factors and their correlation within the metabolic syndrome. The secret of gods. Sousa RA; Manuel GJ; Vicente C Diabetes Metab Syndr; 2019; 13(2):1393-1398. PubMed ID: 31336498 [TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population. Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365 [TBL] [Abstract][Full Text] [Related]
34. Association between metabolic syndrome and 10-year risk of developing cardiovascular disease in a Nigerian population. Oguoma VM; Nwose EU; Skinner TC; Richards RS; Digban KA; Onyia IC Int Health; 2016 Sep; 8(5):354-9. PubMed ID: 27118483 [TBL] [Abstract][Full Text] [Related]
35. The metabolic syndrome and the risk of thrombosis. Dentali F; Romualdi E; Ageno W Haematologica; 2007 Mar; 92(3):297-9. PubMed ID: 17339177 [No Abstract] [Full Text] [Related]
36. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial. Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386 [TBL] [Abstract][Full Text] [Related]
37. [The prevalence of metabolic syndrome in middle-aged in Kaunas population]. Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835 [TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome and cardiovascular disease in elderly people in rural China: a population-based study. Liang Y; Yan Z; Song A; Cai C; Sun B; Jiang H; Qiu C J Am Geriatr Soc; 2013 Jun; 61(6):1036-1038. PubMed ID: 23772734 [No Abstract] [Full Text] [Related]